National Cancer Survivors Day® is an annual celebration of life that is held in hundreds of communities. It is “a CELEBRATION for those who have survived, an INSPIRATION for those recently diagnosed, a gathering of SUPPORT for families, and an OUTREACH to the community.” Read more here: http://www.ncsd.org/.
This year’s theme is Living with a Rare Disease: Day-by-Day, Hand-in-Hand. The Carcinoid Cancer Foundation is proud to be a Rare Disease Day Partner. Learn more about how you can become involved in the United States, http://rarediseaseday.us/, and globally, http://www.rarediseaseday.org/.
Internationally known carcinoid/neuroendocrine cancer experts Thomas M. O'Dorisio, MD and M. Sue O'Dorisio, MD, will be the featured speakers for The Bea Lehming Memorial Lectures in Falls Church, Virginia on Saturday, November 15. The Bea Lehming Memorial Lectures are made possible with contributions form the Carcinoid Cancer Awareness Network (CCAN) and the Captial Area Carcinoid Survivors (CACS) members.
Neuroendocrine tumor patients and caregivers are invited for an afternoon of networking and information gathering, sponsored by the Roswell Park Cancer Institute in Buffalo, New York, on Saturday, October 18.
The PNW Carcinoid/NET Support Group will present a day of learning and support for carcinoid/NET patients and their loved ones at UW Medicine in Seattle, Washington on Saturday, October 25. The featured speakers are Veena Shankaran, MD on "Systemic Therapy Option for Advanced Neuroendocrine Tumors" and Flavio Rocha, MD on "The Role of Local Therapy for Metastatic Carcinoid and PNETs." There will also be presentations by a nutritionist, a yoga and meditation practitioner, and a nurse educator.
Run, walk, or cheer on all participating in the 3rd Anuual Dean Paras Memorial 5K on Sunday, October 12th at University School in Hunting Valley, Ohio. Registration begins at 11:30 am and the Run/Walk starts at 1:00 pm. Malina Papanikolaou has organized the event in memory of her cousin, Dean Paras (pictured), who lost his battle with neuroendocrine cancer at the age of 26 in 2011.&n